After serving from 2016 to 2017 as Interim Provost and Executive Vice Chancellor of UC Davis, Dr. Ken Burtis has returned to his position as Faculty Advisor to the Chancellor and Provost at UC Davis, with primary responsibilities centered on coordination of the planning process for growth of the campus over the next decade, covering the areas of enrollment management, facilities planning and academic resources.
From 2005 to 2011, Dr. Burtis served as Interim Dean and then Dean of the College of Biological Sciences at UC Davis, which includes over 5000 undergraduate students, 450 graduate students and 125 faculty. Named as the first dean of the newly established college in 2006, his involvement with biology at UC Davis spans almost four decades, during which time he has been a student, staff member, professor and administrator. He joined UC Davis as an undergraduate in 1972, earning his bachelor's degree in Biochemistry and Biophysics in 1976, and working until 1979 as a research associate. After earning a PhD in biochemistry and conducting postdoctoral research at Stanford University from 1979 to 1988, he returned to UC Davis as an assistant professor of genetics. Prior to his appointment as dean, Burtis served as chair of the Genetics Graduate Group, vice-chair of the Department of Molecular and Cellular Biology, associate director of the UC Davis Genome Center, and Associate Dean for Undergraduate Academic Programs in the College of Biological Sciences.
Lars Berglund, MD PhD
Professor of Medicine
Senior Associate Dean for Research
Director, UC Davis CTSC
Dr. Berglund is Professor of Medicine, Senior Associate Dean for Research, and Director of NIH-funded Clinical and Translational Science Center at UC Davis. He received his Ph.D. in 1977 and M.D. in 1981, both from University of Uppsala, Sweden. Dr. Berglund was recruited to Columbia University in 1993 and to UC Davis in 2002.
As the Senior Associate Dean for Research, Dr. Berglund oversees all aspects of the School of Medicine research portfolio. In his capacity as the Director of the Clinical and Translational Science Center and the PI for the NIH CTSA award, he is responsible for all CTSC infrastructure activities, including services, education and translational science projects. He currently serves in an advisory capacity to national organizations (NIH, AAMC, AHA, Endocrine Society) and he represents the SOM at the institutional and national level in issues related to research. Dr. Berglund’s research focus is in the area of lipoprotein metabolism and cardiovascular disease and his research is funded by NIH. He has published more than 200 peer-reviewed papers and is a member of the Editorial Board of several journals.